Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
NEW HAVEN, Conn. (WTNH) — A Connecticut lawmaker is pushing for a statewide ban on the sale of small bottles of liquor, commonly referred to as “nips” or “shooters.” State Rep.